Amylyx Pharmaceuticals, Inc. (AMLX)

SEC filing

Amylyx Pharmaceuticals, Inc.

AMLX · CIK 1658551

4 · Sep 14, 2026 · Director, Co-Chief Executive Officer Cohen Joshua B sold 30.46K shares at $32.19/share ($980.5K)

Director, Co-Chief Executive Officer Cohen Joshua B sold 30.46K shares at $32.19/share ($980.5K)

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).